Drrx stock forecast.

On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialDRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.The DRRX shares have gain 15.52% over the last week, with a monthly amount drifted -79.02%, and not seem to be holding Durect Corp [DRRX] stock prices are up 0.44% to $0.61 at the moment. One of the good ways to gauge the recent performance is if the stock's short-term value is rising or falling.Nov 14, 2023 · Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...

Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes.

Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...

DRRX Fair Price, Target Price, vs SPY, Historical gross margin, operating margin, net margin, ROE, cash flow, revenue and EPS. Financial, growth and cost analysisForecast . Price target. 19.38 0.00 0.00%. The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 4 analysts giving stock ratings to DRRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFind the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.

Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ...

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...The Applied Uv stock price gained 9.13% on the last trading day (Friday, 1st Dec 2023), rising from $0.115 to $0.126. During the last trading day the stock fluctuated 17.43% from a day low at $0.111 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -13.45% for this period. Volume fell on the last day by -337 ...Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...

Zacks Equity Research. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that it ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ... Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase …Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ...

DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.

DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottomIf you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...View the latest Lakeland Financial Corp. (LKFN) stock price, news, historical charts, analyst ratings and financial information from WSJ.Real time Durect (DRRX) stock price quote, stock graph, news & analysis.

See historical performance and comparison. View Valuation. Research DURECT's (Nasdaq:DRRX) stock price, latest news & stock analysis. Find everything …

Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

Durect Stock Prediction. AVB. 40Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...eCommerce double-digit growth in Q3 and share buyback of $18.6M. Raised 2023 Adjusted EBITDA range to $75M - $82M and Non-GAAP Net Income range to $7M - $12M.Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin. Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.DRRX Stock Forecast - Is DRRX a buy or sell? Find out now with a free analysis on DURECT. Should I buy or sell DRRX? DRRX Stock Analysis - [Full Report] DRRX Chart by TradingView. Accessories Stocks Animal Stocks Biopharma Stocks Biopharmaceutical Stocks Clinic Stocks Clinical StocksCelebrations may be in order for DURECT Corporation ( NASDAQ:DRRX ) shareholders, with the analysts delivering a...Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

Durect stock is taking a beating on Wednesday as DRRX investors react to results from a Phase 2b clinical trial of larsucosterol.More From InvestorPlace ChatGPT IPO Could Shock the World, Make ...View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Durect DRRX is set to give its latest quarterly ... New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).Instagram:https://instagram. rvmdwhat is in the qqqsmallcap world fundonline day trading course DIRTT Environmental Solutions Ltd. (DRTT) share price prediction for 2023, 2024, 2025, 2026 and 2027. DRTT one year forecast. DIRTT Environmental Solutions stock ... mortgage companies in bankruptcyvoo etf holdings Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ... how to buy a house without a realtor for cash May 26, 2020 · DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%. Stock Price Forecast ... The 3 analysts offering 12-month price forecasts for DURECT Corp have a median target of 32.00 , with a high estimate of 44.00 and a low ... DURECT Corporation Common Stock ( DRRX ) - NasdaqDRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.